†
HR 6164 EAS
the total amount appropriated under sub-
section (a) for such year may not be less
than the percentage constituted by the
amount so reserved for the preceding fiscal
year relative to the total amount appro-
priated under subsection (a) for such pre-
ceding fiscal year, subject to any applicable
provisions in appropriations Acts.
‘‘(C) COMMON FUND STRATEGIC PLANNING
REPORT.—Not later than June 1, 2007, and
every 2 years thereafter, the Secretary, acting
through the Director of NIH, shall submit a re-
port to the Congress containing a strategic plan
for 
funding 
research 
described 
in 
section
402(b)(7)(A)(i) 
(including 
personnel 
needs)
through the Common Fund. Each such plan shall
include the following:
‘‘(i) An estimate of the amounts deter-
mined by the Director of NIH to be appro-
priate for maximizing the potential of such
research.
‘‘(ii) An estimate of the amounts deter-
mined by the Director of NIH to be suffi-
cient only for continuing to fund research
activities previously identified by the Divi-
†
HR 6164 EAS
sion of Program Coordination, Planning,
and Strategic Initiatives.
‘‘(iii) An estimate of the amounts de-
termined by the Director of NIH to be nec-
essary to fund research described in section
402(b)(7)(A)(i)—
‘‘(I) that is in addition to the re-
search activities described in clause
(ii); and
‘‘(II) for which there is the most
substantial need.
‘‘(D) EVALUATION.—During the 6-month
period following the end of the first fiscal year
for which the total amount reserved under sub-
paragraph (B) is equal to 5 percent of the total
amount appropriated under subsection (a) for
such fiscal year, the Secretary, acting through
the Director of NIH, in consultation with the ad-
visory council established under section 402(k),
shall submit recommendations to the Congress
for changes regarding amounts for the Common
Fund.
‘‘(2) TRANS-NIH RESEARCH REPORTING.—
‘‘(A) LIMITATION.—With respect to the total
amount appropriated under subsection (a) for
†
HR 6164 EAS
fiscal year 2008 or any subsequent fiscal year, if
the head of a national research institute or na-
tional center fails to submit the report required
by subparagraph (B) for the preceding fiscal
year, the amount made available for the institute
or center for the fiscal year involved may not ex-
ceed the amount made available for the institute
or center for fiscal year 2006.
‘‘(B) REPORTING.—Not later than January
1, 2008, and each January 1st thereafter—
‘‘(i) the head of each national research
institute or national center shall submit to
the Director of NIH a report on the amount
made available by the institute or center for
conducting or supporting research that in-
volves collaboration between the institute or
center and 1 or more other national re-
search institutes or national centers; and
‘‘(ii) the Secretary shall submit a re-
port to the Congress identifying the percent-
age of funds made available by each na-
tional research institute and national center
with respect to such fiscal year for con-
ducting or supporting research described in
clause (i).
†
HR 6164 EAS
‘‘(C) DETERMINATION.—For purposes of de-
termining the amount or percentage of funds to
be reported under subparagraph (B), any
amounts made available to an institute or center
under section 402(b)(7)(B) shall be included.
‘‘(D) VERIFICATION
OF
AMOUNTS.—Upon
receipt of each report submitted under subpara-
graph (B)(i), the Director of NIH shall review
and, in cases of discrepancy, verify the accuracy
of the amounts specified in the report.
‘‘(E) WAIVER.—At the request of any na-
tional research institute or national center, the
Director of NIH may waive the application of
this paragraph to such institute or center if the
Director finds that the conduct or support of re-
search described in subparagraph (B)(i) is in-
consistent with the mission of such institute or
center.
‘‘(d) TRANSFER AUTHORITY.—Of the total amount ap-
propriated under subsection (a) for a fiscal year, the Direc-
tor of NIH may (in addition to the reservation under sub-
section (c)(1) for such year) transfer not more than 1 per-
cent for programs or activities that are authorized in this
title and identified by the Director to receive funds pursu-
ant to this subsection. In making such transfers, the Direc-
†
HR 6164 EAS
tor may not decrease any appropriation account under sub-
section (a) by more than 1 percent.
‘‘(e) RULE OF CONSTRUCTION.—This section may not
be construed as affecting the authorities of the Director of
NIH under section 401.’’.
(b) ELIMINATION OF OTHER AUTHORIZATIONS OF AP-
PROPRIATIONS.—Title IV of the Public Health Service Act
(42 U.S.C. 281 et seq.) is amended—
(1) by striking the first sentence of paragraph
(5) of section 402(i) (as redesignated by section
102(b));
(2) by striking subsection (e) of section 403A;
(3) by striking subsection (c) of section 404B;
(4) by striking subsection (h) of section 404E;
(5) by striking subsection (d) of section 404F;
(6) by striking subsection (e) of section 404G;
(7) by striking subsection (d) of section 409A;
(8) in section 409B—
(A) in subsection (a), by striking ‘‘under
subsection (e)’’ and inserting ‘‘to carry out this
section’’; and
(B) by striking subsection (e);
(9) by striking subsection (e) of section 409C;
(10) in section 409D—
(A) by striking subsection (d); and
†
HR 6164 EAS
(B) by redesignating subsection (e) as sub-
section (d);
(11) by striking subsection (e) of section 409E;
(12) by striking subsection (c) of section 409F;
(13) in section 409H, by striking—
(A) paragraph (3) of subsection (a);
(B) paragraph (3) of subsection (b);
(C) paragraph (5) of subsection (c); and
(D) paragraph (4) of subsection (d);
(14) by striking subsection (d) of section 409I;
(15) by striking section 417B;
(16) by striking subsection (g) of section 417C;
(17) in section 417D, by striking—
(A) paragraph (3) of subsection (a); and
(B) paragraph (3) of subsection (b);
(18) by striking subsection (d) of section 424A;
(19) by striking subsection (c) of section 424B;
(20) by striking section 425;
(21) by striking subsection (d) of section 434A;
(22) by striking subsection (d) of section 441A;
(23) by striking subsection (c) of section 442A;
(24) in section 445H—
(A) by striking subsection (b); and
(B) in subsection (a), by striking ‘‘(a)’’;
(25) by striking subsection (d) of section 445I;
†
HR 6164 EAS
(26) by striking section 445J;
(27) in section 447A—
(A) by striking subsection (b); and
(B) in subsection (a), by striking ‘‘(a)’’;
(28) by striking subsection (d) of section 447B;
(29) by striking subsection (g) in section 452A;
(30) by striking paragraph (7) in section
452E(b);
(31) in section 452G—
(A) by striking subsection (b); and
(B) in subsection (a), by striking ‘‘(a) EN-
HANCED SUPPORT.—’’;
(32) by striking subsection (d) of section 464H;
(33) by striking subsection (d) of section 464L;
(34) by striking paragraph (4) of section
464N(c);
(35) by striking subsection (e) of section 464P;
(36) by striking subsection (f) of section 464R;
(37) by striking subsection (d) of section 464z;
(38) in section 467—
(A) by striking the first sentence;
(B) by striking ‘‘for such buildings and fa-
cilities’’ and inserting ‘‘for suitable and adequate
buildings and facilities for use of the Library’’;
and
†
HR 6164 EAS
(C) by striking ‘‘The amounts authorized to
be appropriated by this section include’’ and in-
serting ‘‘Amounts appropriated to carry out this
section may be used for’’;
(39) by striking section 468;
(40) in section 481A—
(A) in the matter preceding subparagraph
(A) of subsection (c)(2)—
(i) by striking the term ‘‘under sub-
section (i)(1)’’ and inserting ‘‘to carry out
this section’’; and
(ii) by striking ‘‘under such sub-
section’’ and inserting ‘‘to carry out this
section’’; and
(B) by striking subsection (i);
(41) in subsection (a) of section 481B, by strik-
ing ‘‘under section 481A(h)’’ and inserting ‘‘to carry
out section 481A’’;
(42) by striking subsection (c) in the section
481C that relates to general clinical research centers;
(43) by striking subsection (e) in section 485C;
(44) by striking subsection (l) in section 485E;
(45) by striking subsection (h) in section 485F;
(46) by striking subsection (e) in section 485G;
(47) by striking subsection (d) of section 487;
†
HR 6164 EAS
(48) by striking subsection (c) of section 487A;
and
(49) by striking subsection (c) in the section
487F that relates to a loan repayment program re-
garding clinical researchers.
(c) RULE OF CONSTRUCTION REGARDING CONTINU-
ATION OF PROGRAMS.—The amendment of a program by
a provision of subsection (b) may not be construed as termi-
nating the authority of the Federal agency involved to carry
out the program.
SEC. 104. REPORTS.
(a) REPORT
OF DIRECTOR
OF NIH.—The Public
Health Service Act (42 U.S.C. 201 et seq.), as amended by
section 103(a) of this Act, is amended—
(1) by redesignating section 403A as section
403C;
(2) in section 1710(a), by striking ‘‘section
403A’’ and inserting ‘‘section 403C’’; and
(3) by striking section 403 and inserting the fol-
lowing sections:
‘‘SEC. 402B. ELECTRONIC CODING OF GRANTS AND ACTIVI-
TIES.
‘‘The Secretary, acting through the Director of NIH,
shall establish an electronic system to uniformly code re-
search grants and activities of the Office of the Director and
†
HR 6164 EAS
of all the national research institutes and national centers.
The electronic system shall be searchable by a variety of
codes, such as the type of research grant, the research entity
managing the grant, and the public health area of interest.
When permissible, the Secretary, acting through the Direc-
tor of NIH, shall provide information on relevant literature
and patents that are associated with research activities of
the National Institutes of Health.
‘‘SEC. 403. BIENNIAL REPORTS OF DIRECTOR OF NIH.
‘‘(a) IN GENERAL.—The Director of NIH shall submit
to the Congress on a biennial basis a report in accordance
with this section. The first report shall be submitted not
later than 1 year after the date of the enactment of the Na-
tional Institutes of Health Reform Act of 2006. Each such
report shall include the following information:
‘‘(1) An assessment of the state of biomedical and
behavioral research.
‘‘(2) A description of the activities conducted or
supported by the agencies of the National Institutes of
Health and policies respecting the programs of such
agencies.
‘‘(3) Classification and justification for the pri-
orities established by the agencies, including a stra-
tegic plan and recommendations for future research
initiatives to be carried out under section 402(b)(7)
†
HR 6164 EAS
through the Division of Program Coordination, Plan-
ning, and Strategic Initiatives.
‘‘(4) A catalog of all the research activities of the
agencies, prepared in accordance with the following:
‘‘(A) The catalog shall, for each such
activity—
‘‘(i) identify the agency or agencies in-
volved;
‘‘(ii) state whether the activity was
carried out directly by the agencies or was
supported by the agencies and describe to
what extent the agency was involved; and
‘‘(iii) identify whether the activity was
carried out through a center of excellence.
‘‘(B) In the case of clinical research, the
catalog shall, as appropriate, identify study pop-
ulations by demographic variables and other
variables that contribute to research on minority
health and health disparities.
‘‘(C) Research activities listed in the catalog
shall include, where applicable, the following:
‘‘(i) Epidemiological studies and longi-
tudinal studies.
‘‘(ii) Disease registries, information
clearinghouses, and other data systems.
†
HR 6164 EAS
‘‘(iii) Public education and informa-
tion campaigns.
‘‘(iv) Training activities, including—
‘‘(I) National Research Service
Awards and Clinical Transformation
Science Awards;
‘‘(II) graduate medical education
programs, including information on
the number and type of graduate de-
grees awarded during the period in
which the programs received funding
under this title;
‘‘(III) 
investigator-initiated
awards for postdoctoral training;
‘‘(IV) a breakdown by demo-
graphic variables and other appro-
priate categories; and
‘‘(V) an evaluation and compari-
son of outcomes and effectiveness of
various training programs.
‘‘(v) Clinical trials, including a break-
down of participation by study populations
and demographic variables and such other
information as may be necessary to dem-
onstrate compliance with section 492B (re-
†
HR 6164 EAS
garding inclusion of women and minorities
in clinical research).
‘‘(vi) Translational research activities
with other agencies of the Public Health
Service.
‘‘(5) A summary of the research activities
throughout the agencies, which summary shall be or-
ganized by the following categories, where applicable:
‘‘(A) Cancer.
‘‘(B) Neurosciences.
‘‘(C) Life stages, human development, and
rehabilitation.
‘‘(D) Organ systems.
‘‘(E) Autoimmune diseases.
‘‘(F) Genomics.
‘‘(G) Molecular biology and basic science.
‘‘(H) Technology development.
‘‘(I) Chronic diseases, including pain and
palliative care.
‘‘(J) Infectious diseases and bioterrorism.
‘‘(K) Minority health and health dispari-
ties.
‘‘(L) Such additional categories as the Di-
rector determines to be appropriate.
†
HR 6164 EAS
‘‘(6) A review of each entity receiving funding
under this title in its capacity as a center of excel-
lence (in this paragraph referred to as a ‘center of ex-
cellence’), including the following:
‘‘(A) An evaluation of the performance and
research outcomes of each center of excellence.
‘‘(B) Recommendations for promoting co-
ordination of information among the centers of
excellence.
‘‘(C) Recommendations for improving the
effectiveness, efficiency, and outcomes of the cen-
ters of excellence.
‘‘(D) If no additional centers of excellence
have been funded under this title since the pre-
vious report under this section, an explanation
of the reasons for not funding any additional
centers.
‘‘(b) REQUIREMENT REGARDING DISEASE-SPECIFIC
RESEARCH ACTIVITIES.—In a report under subsection (a),
the Director of NIH, when reporting on research activities
relating to a specific disease, disorder, or other adverse
health condition, shall—
‘‘(1) present information in a standardized for-
mat;
†
HR 6164 EAS
‘‘(2) identify the actual dollar amounts obligated
for such activities; and
‘‘(3) include a plan for research on the specific
disease, disorder, or other adverse health condition,
including a statement of objectives regarding the re-
search, the means for achieving the objectives, a date
by which the objectives are expected to be achieved,
and justifications for revisions to the plan.
‘‘(c) ADDITIONAL REPORTS.—In addition to reports
required by subsections (a) and (b), the Director of NIH
or the head of a national research institute or national cen-
ter may submit to the Congress such additional reports as
the Director or the head of such institute or center deter-
mines to be appropriate.
‘‘SEC. 403A. ANNUAL REPORTING TO INCREASE INTER-
AGENCY COLLABORATION AND COORDINA-
TION.
‘‘(a) COLLABORATION WITH OTHER HHS AGEN-
CIES.—On an annual basis, the Director of NIH shall sub-
mit to the Secretary a report on the activities of the Na-
tional Institutes of Health involving collaboration with
other agencies of the Department of Health and Human
Services.
‘‘(b) CLINICAL TRIALS.—Each calendar year, the Di-
rector of NIH shall submit to the Commissioner of Food
†
HR 6164 EAS
and Drugs a report that identifies each clinical trial that
is registered during such calendar year in the databank of
information established under section 402(i).
‘‘(c) HUMAN TISSUE SAMPLES.—On an annual basis,
the Director of NIH shall submit to the Congress a report
that describes how the National Institutes of Health and
its agencies store and track human tissue samples.
‘‘(d) FIRST REPORT.—The first report under sub-
sections (a), (b), and (c) shall be submitted not later than
1 year after the date of the enactment of the National Insti-
tutes of Health Reform Act of 2006.
‘‘SEC. 403B. ANNUAL REPORTING TO PREVENT FRAUD AND
ABUSE.
‘‘(a) WHISTLEBLOWER COMPLAINTS.—
‘‘(1) IN GENERAL.—On an annual basis, the Di-
rector of NIH shall submit to the Inspector General
of the Department of Health and Human Services,
the Secretary, the Committee on Energy and Com-
merce and the Committee on Appropriations of the
House of Representatives, and the Committee on
Health, Education, Labor, and Pensions and the
Committee on Appropriations of the Senate a report
summarizing the activities of the National Institutes
of Health relating to whistleblower complaints.
†
HR 6164 EAS
‘‘(2) CONTENTS.—For each whistleblower com-
plaint pending during the year for which a report is
submitted under this subsection, the report shall iden-
tify the following:
‘‘(A) Each agency of the National Institutes
of Health involved.
‘‘(B) The status of the complaint.
‘‘(C) The resolution of the complaint to
date.
‘‘(b) EXPERTS AND CONSULTANTS.—On an annual
basis, the Director of NIH shall submit to the Inspector
General of the Department of Health and Human Services,
the Secretary, the Committee on Energy and Commerce and
the Committee on Appropriations of the House of Rep-
resentatives, and the Committee on Health, Education,
Labor, and Pensions and the Committee on Appropriations
of the Senate a report that—
‘‘(1) identifies the number of experts and consult-
ants, including any special consultants, whose serv-
ices are obtained by the National Institutes of Health
or its agencies;
‘‘(2) specifies whether such services were obtained
under section 207(f), section 402(d), or other author-
ity;
†
HR 6164 EAS
‘‘(3) describes the qualifications of such experts
and consultants;
‘‘(4) describes the need for hiring such experts
and consultants; and
‘‘(5) if such experts and consultants make finan-
cial disclosures to the National Institutes of Health or
any of its agencies, specifies the income, gifts, assets,
and liabilities so disclosed.
‘‘(c) FIRST REPORT.—The first report under sub-
sections (a) and (b) shall be submitted not later than 1 year
after the date of the enactment of the National Institutes
of Health Reform Act of 2006.
‘‘SEC. 403C. ANNUAL REPORTING REGARDING TRAINING OF
GRADUATE STUDENTS FOR DOCTORAL DE-
GREES.
‘‘(a) IN GENERAL.—Each institution receiving an
award under this title for the training of graduate students
for doctoral degrees shall annually report to the Director
of NIH, with respect to each degree-granting program at
such institution—
‘‘(1) the percentage of students admitted for
study who successfully attain a doctoral degree; and
‘‘(2) for students described in paragraph (1), the
average time between the beginning of graduate study
and the receipt of a doctoral degree.
†
HR 6164 EAS
‘‘(3) PROVISION
OF
INFORMATION
TO
APPLI-
CANTS.—Each institution described in subsection (a)
shall provide to each student submitting an applica-
tion for a program of graduate study at such institu-
tion the information described in paragraphs (1) and
(2) of such subsection with respect to the program or
programs to which such student has applied.’’.
(b) STRIKING OF OTHER REPORTING REQUIREMENTS
FOR NIH.—
(1) PUBLIC HEALTH SERVICE ACT; TITLE IV.—
Title IV of the Public Health Service Act, as amended
by section 103(b) of this Act, is amended—
(A) in section 404E(b)—
(i) by amending paragraph (3) to read
as follows:
‘‘(3) COORDINATION OF CENTERS.—The Director
of NIH shall, as appropriate, provide for the coordi-
nation of information among centers under para-
graph (1) and ensure regular communication between
such centers.’’; and
(ii) by striking subsection (f) and re-
designating subsection (g) as subsection (f);
(B) in section 404F(b)(1), by striking sub-
paragraphs (F) and (G);
(C) by striking section 407;
†
HR 6164 EAS
(D) in section 409C(b), by striking para-
graph (4) and redesignating paragraphs (5) and
(6) as paragraphs (4) and (5), respectively;
(E) in section 409E, by striking subsection
(d);
(F) in section 417C, by striking subsection
(f);
(G) in section 424B(a)—
(i) in paragraph (1), by adding ‘‘and’’
after the semicolon at the end;
(ii) in paragraph (2), by striking ‘‘;
and’’ and inserting a period; and
(iii) by striking paragraph (3);
(H) in section 429, by striking subsections
(c) and (d);
(I) in section 442, by striking subsection (j)
and redesignating subsection (k) as subsection
(j);
(J) in section 464D, by striking subsection
(j);
(K) in section 464E, by striking subsection
(e);
(L) in section 464T, by striking subsection
(e);
†
HR 6164 EAS
(M) in section 481A, by striking subsection
(h);
(N) in section 485E, by striking subsection
(k);
(O) in section 485H—
(i) by striking ‘‘(a)’’ and all that fol-
lows through ‘‘The Secretary,’’ and insert-
ing ‘‘The Secretary,’’; and
(ii) by striking subsection (b); and
(P) in section 494—
(i) by striking ‘‘(a) If the Secretary’’
and inserting ‘‘If the Secretary’’; and
(ii) by striking subsection (b).
(2) PUBLIC HEALTH SERVICE ACT; OTHER PRO-
VISIONS.—The Public Health Service Act (42 U.S.C.
201 et seq.) is amended—
(A) in section 399E, by striking subsection
(e);
(B) in section 1122—
(i) by striking ‘‘(a) From the sums’’
and inserting ‘‘From the sums’’; and
(ii) by striking subsections (b) and (c);
(C) by striking section 2301;
†
HR 6164 EAS
(D) in section 2354, by striking subsection
(b) and redesignating subsection (c) as subsection
(b);
(E) in section 2356, by striking subsection
(e) and redesignating subsections (f) and (g) as
subsections (e) and (f), respectively; and
(F) in section 2359(b)—
(i) by striking paragraph (2);
(ii) by striking ‘‘ (b) EVALUATION AND
REPORT’’ and all that follows through ‘‘Not
later than 5 years’’ and inserting ‘‘ (b)
EVALUATION.—Not later than 5 years’’;
(iii) by redesignating subparagraphs
(A) through (C) as paragraphs (1) through
(3), respectively; and
(iv) by moving each of paragraphs (1)
through (3) (as so redesignated) 2 ems to
the left.
(3) OTHER ACTS.—Provisions of Federal law are
amended as follows:
(A) Section 7 of Public Law 97–414 is
amended—
(i) in subsection (a)—
(I) in paragraph (2), by inserting
‘‘and’’ at the end;